| INTRODUCTION

Living donor liver transplantation (LDLT) was introduced in Japan in
November 1989 as a life-saving procedure for patients with biliary atresia (BA) due to the scarcity of donors available for deceased donor liver transplantation (DDLT). 1 The shortage of deceased organ donors has led to the development of unique technical, physiological, and logistical innovations in LDLT over the past 28 years.
2,3
The indications for pediatric liver transplantation (LT) include cholestatic liver disease, metabolic liver disease, acute liver failure, hepatic malignancy, vascular disease, graft failure, and others. BA is the most common indication for LT accounting for 50% of all pediatric LT. 4 Untreated infants succumb to either liver cirrhosis or liver failure or both within a year or two of birth. 5 The introduction of the Kasai operation, hepatic portoenterostomy, in the late 1950s contributed to a dramatic improvement in the long-term survival of patients with BA, and this procedure is now accepted as the standard surgical treatment. 6 Currently, the incidence of BA is 1 in 9,640 live births, and the annual number of patients with BA is approximately 100 with a 10-year native liver survival of 52.8%
in Japan. 7 The indications for LT in patients with post-Kasai BA include persistent hyperbilirubinemia, liver cirrhosis, liver failure, gastrointestinal bleeding due to portal hypertension, growth retardation, pruritus, repeated cholangitis, progressive intrapulmonary shunting, hepatopulmonary syndrome, and hepatic malignancy, either alone or in combination. Several large studies have focused on the long-term outcomes of LT for BA. The 5-year recipient survival rate ranged from 82-98% in recent large series. 4, [8] [9] [10] [11] [12] [13] [14] Data on LDLT for patients with BA, however, are limited due to the lack of accumulated experience.
The Japanese Liver Transplantation Society (JLTS), a cooperative research consortium, was established in 1980 with the aim of characterizing and following trends in patient characteristics and survival outcomes at all liver transplant centers in Japan. The JLTS is a mandatory data registry, and all of its data are validated by crosschecking with the national registry of the Japanese Transplantation
Society and the national clinical data base of the Japan Surgical Society.
The aim of this study was to evaluate the largest and longest follow-up cohort in the world of BA patients who have undergone LDLT.
The use of annual LT registry data was approved by the ethics committee of the JLTS.
| PATIENTS AND METHODS
| Study design
We analyzed the data for all living donors and recipients who underwent primary LDLT and were enrolled in the JLTS between the registry's inception in November 1989 and December 2015. The study patients were followed before LDLT, and then yearly thereafter. The following donor data were obtained from the JLTS database: age, sex, height, body weight, blood type, relationship to the recipient, and graft type. The following data were collected from the recipients: age, sex, height, body weight, blood type, and outcome at last follow-up (survival or death).
The number of LDLTs performed in Japan showed an initial increase to a maximum of 562 in 2005 followed by a decrease and return to the status quo of approximately 400 annually. During the study period (November 1989 to December 2015), 7,862 procedures were performed in Japan with a minimum follow-up of 2 years ( Figure 1 ). Of these cases, 2,085 BA recipients with primary LDLT were enrolled in the present study. The annual number of pediatric LDLT cases ranged from 120-140 over the past 5 years. During the same study period, 321 DDLTs were performed for various indications and these patients were excluded from the present study.
| Statistical analyses
Continuous variables are reported as medians and interquartile ranges, and categorical variables are reported as proportions. The cumulative survival is shown with Kaplan-Meier curves, and the differences in survival between groups were analyzed using the log-rank test.
Factors associated with the long-term patient survival were analyzed with Cox regression analyses. Variables with P < .1 in the univariate analysis were included in the multivariate analysis. All recipients were followed until death and/or graft loss or until December 2015. The median follow-up period was 10.6 years (range: 2-26 years). All statistical tests were two-sided, and P < .05 was considered significant. 
| RESULTS
| Donor characteristics
The characteristics of the 2,085 donors and recipients are summarized in Table 1 7.0%) and right posterior sector (n = 10; 0.5%). [15] [16] [17] There were no donor mortalities related to surgery in the present study population. (Table 2 ). There were 206 adult patients (9.9%; ≥18 years old). Figure 2 shows the annual number of LDLTs for BA and the mean age at the time of LDLT, given that 80-100 cases received LDLT annually with a mean age approximately 6-8 years old. Figure 3 shows the LDLT age distribution, of which 66.9% of the recipients of LDLT were ≤ 5 years of age and 55.2% were ≤2 years of age.
| Recipient characteristics
The median body weight at the time of LDLT was 18.6 kg.
Approximately 9.3% of the transplants were performed in recipients that were ≤6 kg and 51.4% were ≤10 kg.
| Patient survival
The survival curves for the patients and the grafts are shown in Figure 4A . There were significant differences in the survival between the patients and their grafts (P < .02).
Recipient and donor factors were analyzed for overall graft survival. The results of the univariate and multivariate analyses are shown in Table 2 . According to the univariate analysis, donor age (≥50 years), donor body mass index (BMI) (≥25 kg/m 2 ), ABO incompatibility, graft type, recipient age (≥18 years), transplant center experience (≥50 cases), and transplant era were significant predictors of the graft survival. The univariate analysis of the factors predicting the graft survival showed no significant associations between the survival and donor sex or the relationship of the donor to the recipient. Factors with P < .1
were included in the multivariate analysis, and the donor BMI, ABO incompatibility, graft type, recipient age, center experience, and transplant era were found to be significant predictors of the overall graft survival (Table 3) .
Although most potential donor candidates had strict diet control prior to the planned LDLT, a high donor BMI (≥25) was an independent risk factor for the graft survival, with a 20-year graft survival of 67.5%, which was significantly worse than that in donors with a BMI <25.
ABO compatibility significantly influenced the overall patient survival, with a 20-year survival rate of 67.5% among patients who received ABO-incompatible grafts ( Figure 4A ). When the cumulative patient survival rate in patients with ABO-incompatible grafts (n = 268) was analyzed according to the recipient age at LDLT, the 20-year graft survival rate was significantly better in recipients <2 years The estimated and actual graft weight were not available in the JLTS database, however, all the recipients received an appropriately sized graft according to the graft-to-recipient weight ratio (GRWR) or the standard liver volume, which was calculated by preoperative CT volumetry. 18, 19 The respective recipient age and BW in reduced LLS, LLS, left lobe, right lobe, and right posterior sector were 7.0 ± 2.0 months and 5.8 ± 1.1 kg, 1.3 ± 2.1 years and 9.7 ± 5.3 kg, 12.0 ± 7.6 years and 33.7 ± 15.5 kg, 22.7 ± 7.4 years and 55.9 ± 9.8 kg and
19.3 ± 7.5 years and 50.7 ± 15.7 kg, respectively. Patients with LLS showed a significantly better long-term graft survival than those who received other types of grafts (Table 4) . Crossing of graft survival lines was noted with a subsequently worse graft survival for the left lobe than for the right lobe at 12 years post-LDLT.
Similarly, the age of recipients was found to be a predicting factor for graft survival, and recipients ≥18 years of age showed a significantly worse graft survival than younger ones, with 20-year graft survival rates of 66.5% (Table 4) . When the graft survival rate was analyzed according to specific age groups, adolescent age (12 to <18 years) showed a significantly worse graft survival rate than the adult age group, and the corresponding crossing of the graft survival line was demonstrated at 12 years post-LDLT ( Figure 5 ).
There are 22 liver transplantation centers that are experienced in performing LDLT for BA. Liver transplant centers can be categorized as low-or high-volume according to the number of cases experienced. The mean annual number of overall liver transplants was ≤ 50
for low-volume centers (11 centers) and >50 for high-volume centers (11 centers). There were significant differences between the low-and high-volume centers in the patient and graft survival (P < .01). The number of LDLTs for BA remained fairly static, with 60-100 transplants performed annually. The study period can be categorized (Table 5) . Furthermore, the JLTS series showed a relatively older age and larger weight at LT than other outstanding global institutions, which may represent a better native liver survival in the Japanese BA registry.
T A B L E 1 Characteristics of donors for living donor liver transplantation in Japan
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The results of the Kasai operation in Japan are excellent, allowing children with BA to reach an ideal age and weight for LT with a consequent reduction in the rate of potential complications when performing LT in relatively small recipients.
In this study, the donor BMI, ABO incompatibility, graft type, recipient age, center experience, and the transplant era were found to be significant predictors of overall graft survival. Recently, the increased prevalence of obesity worldwide has threatened the source and pool of living donors. 20 Obesity has been identified as a strong risk factor for graft steatosis, and is associated with poor graft function and a reduced recipient survival rate. 21 There are several diagnostic modalities, including a liver biopsy, which can be used for Y e a rs afte r tr a n s p la n ta tio n P e rc e n t s u rv iv a l Liver graft size matching is a major factor determining a successful outcome. Older recipients with BA had worse overall graft survival rates in the present study. The use of small-for-size grafts leads to a lower graft survival due to insufficient metabolic and synthetic functions and portal hypertension in older recipients. 18 Although patients with left lobe grafts showed significantly lower survival rates than other type of grafts in the present study, there might be considerable historical precedent. For example, the success of LDLT using left-sided grafts for children with BA led to the use of the same procedure in adolescent recipients in the early 1990s; however, this procedure resulted in a reduction in the short-term graft survival in those recipients. 26 With occasional patient mortalities from smallfor-size grafts impeding the wider use of LDLT in adolescents, many centers have begun to use the right lobe to provide a greater amount of actual graft mass for the recipient in order to achieve a better outcome without compromising the living donor. 27 As the actual graft weight was not available in the present study, we cannot rule out the possible effects of inappropriate graft selection on graft survival for the initial series. Recently, an adolescent age at the time of solid organ transplantation, not only for liver, but also kidney, heart, and lung, has been recognized as a risk factor for poor graft survival. 29, 30 Our findings are consistent with those of a prior study that showed that recipients with BA who were 12 to <18 years of age at LDLT had a higher risk of graft failure than other age groups during long-term follow-up.
The graft survival was worse in adolescents (12 to <18 years) than in adults (≥18 years of age) in the present study, and the corresponding crossing of the graft survival lines was demonstrated at 12 years post-LDLT. With less ischemia, improved donor selection and controlled procedures, LDLT might lead to fewer adverse outcomes than DDLT. It has been speculated that the increased risk of graft loss during adolescence among recipients of solid organ transplantation is due to a lack of adherence to immunosuppression, the transition from pediatric to adult care, and changes in health insurance coverage. 31, 32 Japan has a universal healthcare system and most of the medical expenses before and after LT are covered by Japanese insurance benefits. As such, the influence of changes in health insurance coverage during adolescence may be less marked in Japan than in other countries without similar healthcare systems. The increased risk of graft loss during adolescence is most likely multifactorial, and prospective investigations of the transition process may be necessary to clarify these points.
The optimal timing for LT is crucial for achieving a successful outcome. Several studies have attempted to assess the influence of pre-LT variables on the outcome after LT. Gross et al reported that the UNOS status, liver allograft type, and pre-transplant serum bilirubin level were significant predictors of patient survival, whereas the patient age, weight, and history of Kasai operations were not predictors. 33 Others found that growth failure, age <1 year and immunosuppression regimen were predictors of mortality after LT, whereas a history of Kasai operation, LT era and pediatric end-stage liver disease (PELD) score were not predictors. 34 The PELD score is calculated based on the age, growth failure, albumin, international normalized ratio, and total bilirubin level and is an excellent predictor for the outcome of pediatric LT patients. 35, 36 However, it has been reported that the PELD score in BA patients does not accurately represent the true mortality risk associated with complications of portal hypertension, variceal bleeding, refractory ascites, 
P<0.01
Y e a rs afte r tra n s p la n ta tio n P e r c e n t su rv iv a l and hepatopulmonary syndrome. 37, 38 Although the PELD/model for end-stage liver disease (MELD) score were not available in the present study, the JLTS has attempted to assess the influence of certain pre-LDLT variables, including the PELD/MELD score, on the outcome after LDLT for BA, and a study is now underway along with a nationwide live donor long-term survey. The timing of LDLT for children <5 years of age with BA was significantly younger in the recent era than in an earlier era in the present study. Early referral to a transplant center should be considered when at least one complication of cirrhosis occurs during its natural history, regardless of the PELD/MELD score, especially in an LDLT setting, as it allows the transplant center to provide the most input possible regarding the management strategy for the recipient as well as potential donor candidates. 
AUTHOR CONTRIBUTIONS
M.K.: study design, writing of the paper, K.U., S.S., A.F., H.F., S.S., E.K., E.T., Y.I., S.K., M.S., N.K., H.E., H.O., S.U.: study design, critical revision of the article for clinical content.
DISCLOSURE
The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation.
T A B L E 5 World report of liver transplantation for biliary atresia 
